TIS for Improving Cognitive Impairment Associated With Schizophrenia
NCT: NCT07446478 · RECRUITING
Brief Summary
This study aims to evaluate the efficacy and safety of TIS targeting the hippocampus in ameliorating cognitive impairment associated with schizophrenia (CIAS). Participants will receive TIS twice a day for 2 weeks. Their clinical data, including the baseline clinical symptom scale score, cognitive function, and MRI data, will be collected at baseline and at the end of the 2-week intervention.
Frequently Asked Questions
What is TIS for Improving Cognitive Impairment Associated With Schizophrenia?
TIS for Improving Cognitive Impairment Associated With Schizophrenia is a clinical trial registered under NCT07446478. Current status: RECRUITING.
What is the status of NCT07446478?
The current status of NCT07446478 (TIS for Improving Cognitive Impairment Associated With Schizophrenia) is: RECRUITING.
When did TIS for Improving Cognitive Impairment Associated With Schizophrenia start?
TIS for Improving Cognitive Impairment Associated With Schizophrenia started on 2026-06-24.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.